Wellington Management Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Sell
100,215
-25,819
-20% -$518K ﹤0.01% 1573
2025
Q4
$2.95M Buy
126,034
+736
+0.6% +$16K ﹤0.01% 1515
2025
Q3
$2.5M Sell
125,298
-32,754
-21% -$588K ﹤0.01% 1579
2025
Q2
$2.17M Buy
158,052
+9,974
+7% +$95.7K ﹤0.01% 1562
2025
Q1
$1.64M Buy
148,078
+1,125
+0.8% +$12K ﹤0.01% 1599
2024
Q4
$1.57M Buy
146,953
+9,653
+7% +$116K ﹤0.01% 1632
2024
Q3
$1.74M Sell
137,300
-18,778
-12% -$279K ﹤0.01% 1576
2024
Q2
$2.62M Buy
156,078
+19,337
+14% +$275K ﹤0.01% 1460
2024
Q1
$2.05M Buy
136,741
+32,141
+31% +$525K ﹤0.01% 1516
2023
Q4
$1.57M Buy
104,600
+34,537
+49% +$448K ﹤0.01% 1533
2023
Q3
$982K Buy
+70,063
New +$1.12M ﹤0.01% 1614
2022
Q1
Sell
-238,008
Closed -$2.26M 2228
2021
Q4
$2.26M Sell
238,008
-79,292
-25% -$1.12M ﹤0.01% 1636
2021
Q3
$5.34M Sell
317,300
-1,072,325
-77% -$17M ﹤0.01% 1495
2021
Q2
$21.2M Sell
1,389,625
-264,958
-16% -$4.79M ﹤0.01% 1085
2021
Q1
$32.2M Sell
1,654,583
-186,054
-10% -$3.95M 0.01% 940
2020
Q4
$33.2M Sell
1,840,637
-155,353
-8% -$3.25M 0.01% 900
2020
Q3
$38.5M Sell
1,995,990
-5,602
-0.3% -$127K 0.01% 768
2020
Q2
$52.3M Buy
2,001,592
+906,207
+83% +$22.1M 0.01% 691
2020
Q1
$19.5M Sell
1,095,385
-126,012
-10% -$3.4M 0.01% 880
2019
Q4
$40.8M Sell
1,221,397
-95,869
-7% -$2.62M 0.01% 814
2019
Q3
$31.4M Sell
1,317,266
-99,906
-7% -$3.27M 0.01% 848
2019
Q2
$50.9M Sell
1,417,172
-35,065
-2% -$1.29M 0.01% 751
2019
Q1
$53.6M Buy
1,452,237
+479,083
+49% +$20.1M 0.01% 715
2018
Q4
$41.9M Sell
973,154
-20,632
-2% -$928K 0.01% 763
2018
Q3
$46.9M Buy
993,786
+7,126
+0.7% +$331K 0.01% 822
2018
Q2
$49.1M Buy
986,660
+46,785
+5% +$2.72M 0.01% 799
2018
Q1
$46.7M Buy
939,875
+420,785
+81% +$21.1M 0.01% 806
2017
Q4
$19.3M Buy
519,090
+229,828
+79% +$8.18M ﹤0.01% 1079
2017
Q3
$9.12M Sell
289,262
-463,478
-62% -$10.2M ﹤0.01% 1291
2017
Q2
$13.6M Buy
+752,740
New +$13.1M ﹤0.01% 1132

Other funds holding URGN